U-Chart Analysis:Sumitomo Pharma Co., Ltd.:4506

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Sumitomo Pharma Co., Ltd. Go to web site 4506 Medicals 東証プライム March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Sumitomo Pharma Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Sumitomo Pharma Co., Ltd. Balance Sheet 2023年3月期 Sumitomo Pharma Co., Ltd. Balance Sheet 2022年3月期 Sumitomo Pharma Co., Ltd. Balance Sheet 2021年3月期 Sumitomo Pharma Co., Ltd. Balance Sheet 2020年3月期 Sumitomo Pharma Co., Ltd. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents 143,478 202,984 193,698 101,708 137,296
Other Current AssetsHelp 238,382 296,537 266,097 262,382 235,972
Tangible Fixed AssetsHelp 58,909 64,091 64,966 65,748 59,485
Intangible Fixed AssetHelp 329,314 398,692 383,406 421,029 171,390
Investments and OthersHelp 155,244 150,559 223,468 232,203 131,226
Total AssetsHelp 1,134,742 1,308,007 1,308,127 1,256,534 834,717
Total Current LiabilitiesHelp 483,865 456,156 463,698 698,844 308,599
Total Long-term LiabilitiesHelp 244,128 243,963 263,859 25,020 27,980
Shareholder's EquityHelp 406,749 607,888 580,570 532,670 498,138
Total LiabilitiesHelp 1,134,742 1,308,007 1,308,127 1,256,534 834,717

Sumitomo Pharma Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Sumitomo Pharma Co., Ltd. Profit and Loss Account 2023年3月期 Sumitomo Pharma Co., Ltd. Profit and Loss Account 2022年3月期 Sumitomo Pharma Co., Ltd. Profit and Loss Account 2021年3月期 Sumitomo Pharma Co., Ltd. Profit and Loss Account 2020年3月期 Sumitomo Pharma Co., Ltd. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales 555,544 560,035 515,952 482,732 459,267
Total Sales 555,544 560,035 515,952 482,732 459,267
Cost of SalesHelp 178,494 157,116 137,645 129,045 113,553
Other Costs and RevenueHelp 451,562 346,506 322,088 312,934 297,087
Total CostsHelp 630,056 503,622 459,733 441,979 410,640
Net RevenueHelp 377,050 402,919 378,307 353,687 345,714
Earnings Before TaxHelp -47,920 82,961 77,851 83,947 65,046
Net IncomeHelp -74,512 56,413 56,219 40,753 48,627
Net Income -74,512 56,413 56,219 40,753 48,627

Sumitomo Pharma Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Sumitomo Pharma Co., Ltd. Cash Flow Statement 2023年3月期 Sumitomo Pharma Co., Ltd. Cash Flow Statement 2022年3月期 Sumitomo Pharma Co., Ltd. Cash Flow Statement 2021年3月期 Sumitomo Pharma Co., Ltd. Cash Flow Statement 2020年3月期 Sumitomo Pharma Co., Ltd. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help 10,802 31,239 135,601 46,128 48,711
Investing Cash Flow(ICF)Help 52,419 -18,278 8,875 -312,684 -35,049
Financing Cash FlowHelp -146,817 -21,426 -57,215 231,081 -28,645
Exchange Difference of Cash and Cash EquivalentsHelp 24,090 17,751 4,729 -113 4,504
Net Increase and Decrease in Cash and Cash Equivalentsn -59,506 9,286 91,990 -35,588 -10,479

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Sumitomo Pharma Co., Ltd.

Company where related level is highHelp

TAISHO PHARMACEUTICAL CO.,LTD.
Kidswell Bio Corporation
RaQualia Pharma Inc.
Nichi-Iko Pharmaceutical Co.,Ltd.
MIZUHO MEDY CO.,LTD.
Eisai Co.,Ltd.
EIKEN CHEMICAL CO.,LTD.
SEIKAGAKU CORPORATION
Immuno-Biological Laboratories Co., Ltd.
KAINOS Laboratories,Inc.